Pharma Journalist 8769 posts 0 comments

Mylan N.V., today announced the successful acquisition of the global rights to the Cold-EEZE brand cold remedy line from ProPhase Labs, Inc. The transaction provides Mylan all assets…
Read More...

Vanda Pharmaceuticals Inc. announced that it has entered into a license agreement with UC San Francisco (UCSF), under which Vanda will acquire an exclusive worldwide license from UCSF…
Read More...

Perrigo Company plc, a leading global provider of Quality Affordable Healthcare Products announced that it has completed the divestiture of its rights to the royalty stream from global…
Read More...

Orexigen Therapeutics, Inc. announced that its wholly owned subsidiary, Orexigen Therapeutics Ireland Ltd., and Bruno Farmaceutici S.p.A. (Bruno) have executed a distributorship…
Read More...

Allergan plc, a leading global pharmaceutical company and Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative…
Read More...

Perrigo Company plc, a leading global provider of Quality Affordable Healthcare Products, today announced it has completed the divestiture of its rights to the royalty stream from…
Read More...

Orexigen Therapeutics, Inc. announced that its wholly owned subsidiary, Orexigen Therapeutics Ireland Ltd., and Bruno Farmaceutici S.p.A. (Bruno) have executed a distributorship…
Read More...

Allergan plc, a leading global pharmaceutical company and Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative…
Read More...

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, today…
Read More...

Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), has issued a positive opinion, recommending an…
Read More...